BG Medicine, Inc. is a life sciences company, which engages in the provision of developing and delivering innovative solutions for healthcare providers that provide insight and transform the clinical care of heart failure and related disorders. The firm distributes products such as BGM Galectin-3 to clinical laboratories, hospitals, and healthcare providers. The company was founded in February 2000 by Jan van der Greef and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of BG Medicine Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. BG Medicine Inc market cap is $1,137.00.
What is the 52-week high for BG Medicine Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. BG Medicine Inc 52 week high is $0.0001 as of February 25, 2026.